Recent advancements in personalized management of prostate cancer biochemical recurrence after radical prostatectomy.

Journal: Current opinion in urology
Published Date:

Abstract

PURPOSE OF REVIEW: Biochemical recurrence (BCR) after radical prostatectomy exhibits heterogeneous prognostic implications. Recent advancements in imaging and biomarkers have high potential for personalizing care.

Authors

  • Fabian Falkenbach
    Martini-Klinik Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Jonas Ekrutt
    Martini-Klinik Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Tobias Maurer
    Martini-Klinik Prostate Cancer Center, Hamburg, Germany.

Keywords

No keywords available for this article.